Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, B-Cell 9Lymphoma, Non-Hodgkin 7Recurrence 6Multiple Myeloma 4Leukemia, Myeloid, Acute 4Lymphoma, Mantle-Cell 3Lymphoma 3Burkitt Lymphoma 3Lymphoma, Follicular 2Solid Tumors 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Pyloric Stenosis, Hypertrophic 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Platinum-Resistant Ovarian Carcinoma 1Plasmacytoma 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1Lymphoma, B-Cell, Marginal Zone 1Liver Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1

Interventions

Cyclophosphamide 7acalabrutinib 4pirtobrutinib 3fludarabine 3Rituximab 3fludarabine phosphate 2Vincristine 2Melphalan 2Doxorubicin 2thymoglobulin 1obinutuzumab 1idecabtagene vicleucel 1ibrutinib 1Stem Cell Transplantation 1Prednisone 1Prednisolone 1Mycophenolic Acid 1Mesna 1Immunotherapy, Adoptive 1Filgrastim 1Diet 1Bone Marrow Transplantation 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Leukemia, B-Cell × Immunotherapy, Adoptive × Clear all
NCT06355739 2024-04-09

CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡